Increased Risk of Dementia in Patients with Antidepressants: A Meta-Analysis of Observational Studies

Behavioural Neurology

Volumn 2018, Issue , 2018, Pages

  Wang, Yao Chin ^a,b   Tai, Po An ^c   Poly, Tahmina Nasrin ^a   Islam, Md Mohaimenul ^a   Yang, Hsuan Chia ^a,c   Wu, Chieh Chen ^a   Li, Yu Chuan ^a,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b MIN SHENG GENERAL HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; DEMENTIA; FEMALE; FOLLOW UP; HUMAN; MALE; META ANALYSIS; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEWCASTLE-OTTAWA SCALE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; CHEMICALLY INDUCED; DEPRESSION; RISK FACTOR;

ANTIDEPRESSIVE AGENTS; DEMENTIA; DEPRESSION; FEMALE; HUMANS; MALE; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 85054968651     PISSN: 09534180     EISSN: 18758584     Source Type: Journal    
DOI: 10.1155/2018/5315098     Document Type: Review

References (28)

1. Islam M. M., Iqbal U., Walther B., Atique S., Dubey N. K., Nguyen P.-A., Poly T. N., Masud J. H. B., Li Y.-C. (. J.)., Shabbir S.-A., Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis. Neuroepidemiology 2017, 47, 3-4, 181-191, 10.1159/000454881, 2-s2.0-85008343596
2. Wimo A., Jönsson L., Bond J., Prince M., Winblad B., Alzheimer Disease International, The worldwide economic impact of dementia 2010. Alzheimer's & Dementia 2013, 9, 1, 1-11.e3, 10.1016/j.jalz.2012.11.006, 2-s2.0-84872119357, 23305821
3. Wu C. K., Yang Y. H., Lin T. T., Tsai C. T., Hwang J. J., Lin J. L., Chen P. C., Chiang F. T., Lin L. Y., Statin use reduces the risk of dementia in elderly patients: a nationwide data survey and propensity analysis. Journal of Internal Medicine 2015, 277, 3, 343-352, 10.1111/joim.12262, 2-s2.0-84927172893, 24766342
4. Profenno L. A., Porsteinsson A. P., Faraone S. V., Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biological Psychiatry 2010, 67, 6, 505-512, 10.1016/j.biopsych.2009.02.013, 2-s2.0-76849101075, 19358976
5. Ivan C. S., Seshadri S., Beiser A., Au R., Kase C. S., Kelly-Hayes M., Wolf P. A., Dementia after stroke: the Framingham Study. Stroke 2004, 35, 6, 1264-1268, 10.1161/01.STR.0000127810.92616.78, 2-s2.0-2542626089, 15118167
6. Tsai C.-Y., Yang H.-C., Islam M., Hsieh W.-S., Juan S.-H., Chen J.-C., Khan H. A. A., Jian W.-S., Psychotropic medications prescribing trends in adolescents: a nationwide population-based study in Taiwan. International Journal for Quality in Health Care 2017, 29, 6, 861-866, 10.1093/intqhc/mzx123, 2-s2.0-85040602135, 29036295
7. Byers A. L., Yaffe K., Depression and risk of developing dementia. Nature Reviews Neurology 2011, 7, 6, 323-331, 10.1038/nrneurol.2011.60, 2-s2.0-79958234542, 21537355
8. Shilyansky C., Williams L. M., Gyurak A., Harris A., Usherwood T., Etkin A., Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study. The Lancet Psychiatry 2016, 3, 5, 425-435, 10.1016/S2215-0366(16)00012-2, 2-s2.0-84961226056, 26995298
9. Schmitt J., Wingen M., Ramaekers J., Evers E., Riedel W., Serotonin and human cognitive performance. Current Pharmaceutical Design 2006, 12, 20, 2473-2486, 10.2174/138161206777698909, 2-s2.0-33745762580, 16842171
10. Liberati A., Altman D. G., Tetzlaff J., Mulrow C., Gøtzsche P. C., Ioannidis J. P. A., Clarke M., Devereaux P. J., Kleijnen J., Moher D., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine 2009, 6, 7, article e1000100, 10.1371/journal.pmed.1000100, 2-s2.0-68049137869, 19621070
11. Poly T. N., Islam M. M., Walther B. A., Yang H. C., Nguyen P. A., Huang C. W., Shabbir S. A., Li Y. C. (. J.)., Exploring the association between statin use and the risk of Parkinson's disease: a meta-analysis of observational studies. Neuroepidemiology 2017, 49, 3-4, 142-151, 10.1159/000480401, 2-s2.0-85039156497, 29145202
12. Islam M. M., Yang H.-C., Nguyen P.-A., Poly T. N., Huang C.-W., Kekade S., Khalfan A. M., Debnath T., Li Y.-C. J., Abdul S. S., Exploring association between statin use and breast cancer risk: an updated meta-analysis. Archives of Gynecology and Obstetrics 2017, 296, 6, 1043-1053, 10.1007/s00404-017-4533-3, 2-s2.0-85029741206, 28940025
13. Stang A., Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology 2010, 25, 9, 603-605, 10.1007/s10654-010-9491-z, 2-s2.0-77957661914, 20652370
14. Higgins J. P., Green S., Cochrane Handbook for Systematic Reviews of Interventions version 5.1. 0 2011, The cochrane collaboration
15. Lee C., Lin C.-L., Sung F.-C., Liang J.-A., Kao C.-H., Antidepressant treatment and risk of dementia: a population-based, retrospective case-control study. The Journal of Clinical Psychiatry 2016, 77, 1, 117-122,. quiz 122 10.4088/JCP.14m09580, 2-s2.0-84957802204, 26845268
16. Lee C. W.-S., Lin C.-L., Lin P.-Y., Thielke S., Su K.-P., Kao C.-H., Antidepressants and risk of dementia in migraine patients: a population-based case-control study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2017, 77, 83-89, 10.1016/j.pnpbp.2017.04.006, 2-s2.0-85017363309, 28392483
17. Wang C., Gao S., Hendrie H. C., Kesterson J., Campbell N. L., Shekhar A., Callahan C. M., Antidepressant use in the elderly is associated with an increased risk of dementia. Alzheimer Disease and Associated Disorders 2016, 30, 2, 99-104, 10.1097/WAD.0000000000000103, 2-s2.0-84944348203, 26295747
18. Then C.-K., Chi N.-F., Chung K.-H., Kuo L., Liu K.-H., Hu C.-J., Shen S.-C., Lin Y.-K., Risk analysis of use of different classes of antidepressants on subsequent dementia: a nationwide cohort study in Taiwan. PLoS One 2017, 12, 4, article e0175187, 10.1371/journal.pone.0175187, 2-s2.0-85017281749, 28384235
19. Goveas J. S., Hogan P. E., Kotchen J. M., Smoller J. W., Denburg N. L., Manson J. A. E., Tummala A., Mysiw W. J., Ockene J. K., Woods N. F., Espeland M. A., Wassertheil-Smoller S., Depressive symptoms, antidepressant use, and future cognitive health in postmenopausal women: the Women's Health Initiative Memory Study. International Psychogeriatrics 2012, 24, 8, 1252-1264, 10.1017/S1041610211002778, 2-s2.0-84862287529, 22301077
20. Higgins J. P., Green S., Cochrane Handbook for Systematic Reviews of Interventions 2011, John Wiley & Sons
21. Jorm A. F., History of depression as a risk factor for dementia: an updated review. Australian & New Zealand Journal of Psychiatry 2016, 35, 6, 776-781, 10.1046/j.1440-1614.2001.00967.x, 2-s2.0-0035670095
22. Karlsson I. K., Bennet A. M., Ploner A., Andersson T. M.-L., Reynolds C. A., Gatz M., Pedersen N. L., Apolipoprotein E ϵ 4 genotype and the temporal relationship between depression and dementia. Neurobiology of Aging 2015, 36, 4, 1751-1756, 10.1016/j.neurobiolaging.2015.01.008, 2-s2.0-84925297197, 25670333
23. Meng X., D'arcy C., Apolipoprotein E gene, environmental risk factors, and their interactions in dementia among seniors. International Journal of Geriatric Psychiatry 2013, 28, 10, 1005-1014, 10.1002/gps.3918, 2-s2.0-84883553670, 23255503
24. Carvalho A., Miskowiak K., Hyphantis T., Kohler C., Alves G., Bortolato B., Sales P. G., Machado-Vieira R., Berk M., McIntyre R., Cognitive dysfunction in depression-pathophysiology and novel targets. CNS & Neurological Disorders-Drug Targets 2014, 13, 10, 1819-1835, 10.2174/1871527313666141130203627
25. Steffens D. C., Chung H., Krishnan K. R. R., Longstreth W. T., Carlson M., Burke G. L., Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly: the cardiovascular health study. Stroke 2008, 39, 3, 857-862, 10.1161/STROKEAHA.107.498097, 2-s2.0-41249089028, 18239166
26. Islam M. M., Iqbal U., Walther B. A., Nguyen P.-A., Li Y.-C. J., Dubey N. K., Poly T. N., Masud J. H. B., Atique S., Syed-Abdul S., Gender-based personalized pharmacotherapy: a systematic review. Archives of Gynecology and Obstetrics 2017, 295, 6, 1305-1317, 10.1007/s00404-017-4363-3, 2-s2.0-85027885312, 28378180
27. Keers R., Aitchison K. J., Gender differences in antidepressant drug response. International Review of Psychiatry 2010, 22, 5, 485-500, 10.3109/09540261.2010.496448, 2-s2.0-78149255590, 21047161
28. Kundi M., Causality and the interpretation of epidemiologic evidence. Ciência & Saúde Coletiva 2007, 12, 2, 419-428, 10.1590/S1413-81232007000200018, 2-s2.0-34147174431, 17680097